毒理学研究(英文)(Toxicology Research)(国际刊号) 知网目次
- 主管单位:
- 主办单位:
中国毒理学会与英国毒理学会
- 国际刊号:
2045-452X;EISSN 2045-4538
- 国内刊号:
- 学科分类:
- 字数:
-
- 有无基金:
- 周期:
国际号刊-双月刊
- 特殊属性:
外文期刊
- 电话:
- 邮箱:
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次
- 级别:
期刊简介
《毒理学研究(英文)(Toxicology Research)(国际刊号)》期刊已被查看: 次
更新频次
单位占比
一作占比
投稿指南
1、该刊只有国际刊号。
2、投稿方式:在线投稿。
3、刊内网址:https://academic.oup.com/toxres
4、投稿网址:https://mc.manuscriptcentral.com/toxres
5、主办单位网址:http://www.chntox.org/publish.aspx
(中国毒理学会)
6、出刊日期:双月刊,一年出版6期。
7、微信公众号:中国毒理学会(cst66932387)
2021年10月12日星期二
《毒理学研究(英文)》(Toxicology Research)期刊简介
由中国毒理学会与英国毒理学会合办、英国皇家化学会(RSC)出版社出版发行的《Toxicology Research》首度影响因子(IF)为3.27。《Toxicology Research》杂志是发表毒理学基础和应用研究成果的期刊,涉及领域包括环境与职业化学物毒性及其机制、食品和药品毒性及其机制、人群健康效应和风险/安全性评价等。《Toxicology Research》创办之时的定位就直指国际毒理学领域的顶尖学术刊物,首刊在2012年7月份发行,目前杂志已经刊出14期,共发表了100篇文章。《Toxicology Research》的杂志主编是来自英国帝国理工大学的Nigel J Gooderham教授,副主编7位,其中2位来自中国毒理学会,分别是学会理事长、军事医学科学院周平坤教授和学会付秘书长中山大学陈雯教授。主编Gooderham教授于期刊影响因子公布的第二天(8月1日)特地向中国毒理学会和英国毒理学会发来祝贺和致谢信,感谢中英两学会的共同合作,以及编委会、编辑部全体团队对该杂志的支持和辛勤付出,并鼓励同道继续支持和踊跃投稿。
《毒理学研究(英文)》(Toxicology Research)作者指南
【官网信息】
Author Guidelines
General Instructions
Scope
Toxicology Research aims to publish cutting edge research that is excellent and innovative, that drives toxicology and has international impact. Articles should cover chemical or biological aspects of the toxic response and the mechanisms involved.
The journal’s scope includes the following.
Carcinogenicity, including studies on mode of action of carcinogens, genotoxicity and mutation.
Biomarkers of toxicity, including studies on their identification, validation, and utilization.
Computational and predictive toxicology, including in vitro, in vivo and in silico studies of toxicity and the development of predictive tools and models. Work considering alternative methods to in vivo studies is encouraged.
Systems toxicology, studies that describe the toxicological effects of chemicals on specific organs or systems (for example, immune, nervous, reproductive, respiratory), including studies that incorporate genomic, metabonomic and proteomic data.
Risk assessment, studies which provide toxicological data or information—such as hazard identification, and dose-response assessment.
Exposure assessment for the development of risk assessments or regulation.
Environmental toxicology, studies reporting toxicology data for organisms within an ecosystem are encouraged if there is a wider benefit to human health. This includes studies on lower organisms as models for the human toxic response, studies which provide cross-species perspective, or studies on organisms which lie within the human food chain. Studies where the toxicological conclusions are only relevant for a specific lower organism should be submitted to a more specialized journal.
Clinical toxicology, studies relating to clinical trials or medicinal applications of toxicological research, including translational toxicology, and studies translating a molecular understanding of the toxic response to clinical application.
Nanotoxicology, an adequate characterization of relevant physico-chemical properties of the nanoparticles is required for studies on the biochemical or molecular mechanisms of toxic responses to nano materials. Studies on common nanomaterials which are of direct relevance to human health are strongly encouraged. For studies reporting the synthesis and characterization of novel nanomaterials, the rationale for reporting the toxicological effect of these materials must be justified.
Food toxicology, toxicological studies of chemical extracts related to food and nutrition. Studies that involve uncharacterized extracts or in which the food substance is only of limited or local interest should be submitted elsewhere.
Analytical metrology, including studies of new analytical methods and applications.
The following areas are not within the scope of Toxicology Research:
Studies that focus only on toxic contaminant levels in the environment or in populations, and the sources, transport or fate of these contaminants.
Biomarkers for the detection of contaminants in the environment.
Environmental contaminant studies that do not discuss toxic effects on a molecular level.
Ethical policies
Authors should observe high standards with respect to publication best practice. Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of work are all unacceptable practices. Any cases of ethical or publication malpractice are treated very seriously and will be managed in accordance with the Commission on Publication Ethics (COPE) guidelines. Further information about OUP’s ethical policies is available.
Data policies
OUP’s policy on data and privacy.
ORCID
Toxicology Research requires submitting authors to provide an ORCID iD at submission to the journal. More information on ORCID and the benefits of using an ORCID iD is available. If you do not already have an ORCID iD, you can register for free via the ORCID website.
Third-party permissions
In order to reproduce any third party material, including tables, figures, or images, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse. When seeking to reproduce any kind of third party material authors should request the following:
non-exclusive rights to reproduce the material in the specified article and journal;
electronic rights, preferably for use in any form or medium;
the right to use the material for the life of the work; and
world-wide English-language rights.
It is particularly important to clear permission for use in both the print and online versions of the journal, and we are not able to accept permissions which carry a time limit because we retain journal articles as part of our online journal archive. Further guidelines on clearing permissions.
Permissions regarding re-use of OUP material
Guidelines on permissions for the reuse of OUP material.
Funder policies
Information about compliance with funder requirements including PubMed/PMC deposits.
Article types and submission
Toxicology Research publishes:
Original Article
Communications
Reviews
Viewpoints
See below for more information about these article types. All manuscripts are submitted and reviewed via the journal’s web-based manuscript submission system, ScholarOne Manuscripts. To submit to the journal go to the submission website. New authors should create an account prior to submitting a manuscript for consideration.
Original Article
These contain original scientific work that has not been published previously. However, work that has appeared in print in a short form such as a Communication is normally acceptable. Please note that full papers based on Communications must represent a substantial extension of the original material. Full papers should be written in a concise fashion.
Typical articles would be between three and seven pages in length, and articles would not normally exceed 10 pages. Authors are encouraged to supply any additional procedures, data and other material in an electronic supplementary information file.
Communications
Toxicology Research Communications contain novel scientific work of such importance that rapid publication is desirable (typically 50% faster than a full paper). Authors should briefly indicate in a covering letter the reasons why they feel that publication of their work as a Communication is justified.
Communications should be written in a concise fashion, with a recommended length of between two and four journal pages. Authors are encouraged to supply any additional procedures, data and other material in an electronic supplementary information file.
……
更多详情:
https://academic.oup.com/toxres/pages/General_Instructions
中国全科医学发文选摘
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
《毒理学研究(英文)(Toxicology Research)(国际刊号)》同类基础医学期刊
-
免疫学杂志
CSCD,科核,武A-
CN中文-月刊影响因子1.763
-
病毒学报
北核,CSCD,科核,武A-
CN中文-双月刊影响因子1.439
-
中国临床解剖学杂志
北核,科核,CSCD扩,武B+
CN中文-双月刊影响因子0.831
-
中国健康心理学杂志
CACJ-核心,武B+
CN中文-月刊影响因子2.05
-
中国生物医学工程学报
北核,CSCD,科核,武A
CN中文-双月刊影响因子1.392
-
解剖学报
CSCD,科核,武B+
CN中文-双月刊影响因子0.931
-
中国疫苗和免疫
北核,CSCD,科核,高T2,武B+
CN中文-双月刊影响因子2.521
-
生物医学工程学杂志
北核,科核,武A,EI(中国2024)
CN中文-双月刊影响因子1.641
常见问题
-
哪些期刊可以用来评职称?
1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。
-
你们的服务可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
请问发表一篇期刊的费用是多少?
期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。
-
如果发表不成功可以退款吗?
如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。
-
请问文章发表需要多长时间?
不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。
-
期刊发表能加急见刊吗?
为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。